Oramed Pharmaceuticals (ORMP) Insider Trading & Ownership $2.47 -0.15 (-5.73%) Closing price 04:00 PM EasternExtended Trading$2.46 -0.01 (-0.20%) As of 07:11 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Oramed Pharmaceuticals (NASDAQ:ORMP) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage13.70%Number OfInsiders Buying(Last 3 Years)2Amount OfInsider Buying(Last 3 Years)$293,240.00Number OfInsiders Selling(Last 3 Years)2Amount OfInsider Selling(Last 3 Years)$261,328.75 Get ORMP Insider Trade Alerts Want to know when executives and insiders are buying or selling Oramed Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address ORMP Insider Buying and Selling by Quarter Remove Ads Oramed Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails1/10/2025Brad KnottU.S. Congress Member (R-NC)Sell$2.39$15,001 - $50,0003/16/2023Nadav KidronCEOBuy26,000$2.04$53,040.00 3/14/2023Nadav KidronCEOBuy100,000$2.01$201,000.00 3/13/2023Yadin RozovDirectorBuy20,000$1.96$39,200.00 1/3/2023Michael RabinowitzInsiderSell13,325$12.55$167,228.75 3/21/2022Kevin RakinDirectorSell10,000$9.41$94,100.00 (Data available from 1/1/2013 forward) ORMP Insider Trading Activity - Frequently Asked Questions Who is on Oramed Pharmaceuticals's Insider Roster? The list of insiders at Oramed Pharmaceuticals includes Kevin Rakin, Michael Rabinowitz, Nadav Kidron, and Yadin Rozov. Learn more on insiders at ORMP. What percentage of Oramed Pharmaceuticals stock is owned by insiders? 13.70% of Oramed Pharmaceuticals stock is owned by insiders. Learn more on ORMP's insider holdings. Which Oramed Pharmaceuticals insiders have been buying company stock? The following insiders have purchased ORMP shares in the last 24 months: Nadav Kidron ($254,040.00), and Yadin Rozov ($39,200.00). How much insider buying is happening at Oramed Pharmaceuticals? Insiders have purchased a total of 146,000 ORMP shares in the last 24 months for a total of $293,240.00 bought. Which members of congress are trading Oramed Pharmaceuticals? Brad Knott (R-NC) has sold shares of Oramed Pharmaceuticals in the last year totaling $32,500. Oramed Pharmaceuticals Key ExecutivesMr. Nadav Kidron Esq. (Age 50)President, CEO & Executive Chairman Compensation: $754.3kMr. David Silberman CPA (Age 40)CFO & Treasurer Compensation: $259.53kDr. Miriam Kidron Ph.D. (Age 84)Chief Scientific Officer & Director Compensation: $503.95kMr. Joshua Hexter (Age 54)Chief Operating & Business Officer Compensation: $326.94k More Insider Trading Tools from MarketBeat Related Companies ProKidney Insider Trading Tourmaline Bio Insider Trading Alpha Teknova Insider Trading Esperion Therapeutics Insider Trading REGENXBIO Insider Trading Prime Medicine Insider Trading Benitec Biopharma Insider Trading Terns Pharmaceuticals Insider Trading Atyr PHARMA Insider Trading Acelyrin Insider Trading Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Companies Buying Back Stock—Why It MattersInsider Scoop: 4 Stocks Insiders Are Buying and Selling2 Stocks Insiders Are Buying and 1 They're Selling3 Stocks With Robust Growth Outlooks Insiders Are BuyingMETA Stock: Insider Selling Ramps Up—What It Means for Investors This page (NASDAQ:ORMP) was last updated on 3/12/2025 by MarketBeat.com Staff From Our PartnersA deadly mistake in my prediction…I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredTrump Orders 'National Digital Asset Stockpile'Trump Orders ‘National Digital Asset Stockpile’ THIS could be the coin they choose…Crypto 101 Media | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | SponsoredDOGE’s Next Move: Not what you thinkDonald Trump, Elon Musk and the Department of Government Efficiency have kept their word. Moving even faste...Weiss Ratings | SponsoredAlert: DOGE goes liveElon will most likely be at the helm of it all. And just days from now, could bring about the biggest econo...Altimetry | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredThis Crypto Is Set to Explode in FebruaryThe world's central banks are making bold moves—and it's raising eyebrows. What do they know that you don...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oramed Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oramed Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ORMP Stock Alerts